Even as there has been seen slowing down in primary market activity amid the second Covid 19 wave, as per Prime Database which is India's first and still the only database dedicated to the primary capital market covering fund raising by the Indian corporate sector and the Government through equity, debt or securitisation, in India or abroad, India Inc. continues to file for public offers.
Since the beginning of the new FY22, a total of 9 companies have filed the DRHP for raising almost Rs. 19660 crore or appx $2.66 billion.
In the first quarter January-March of calendar year, 16 companies floated their IPOs and only of the counter saw listing in the month gone by, Macrotech Developers. Presently as were bankers even as the Covid 19 wave is peaking, companies have not subdued their IPO plans and are swiftly doing the due formalities to throw open their offers when the market seems conducive for IPOs.
"In the last three months a very strong IPO pipeline has built up. The filings that we saw in the last few weeks are all companies that have been working on their draft prospectuses for the last three-six months. While work on new deals has gone a little slow, companies that were in advanced stages are not looking to defer their IPO plans and continuing to file the prospectus," said a Mumbai-based investment banker, who did not wish to be named.
Companies that have filed DRHP include
|Jana Small Finance Bank||Rs. 1100 crore|
|Zomato||Rs. 8250 crore|
|Tatva Chintan Pharma||Rs. 450 crore|
|Shriram Properties||Rs. 800 crore|
|Aditya Birla AMC||Rs. 2100 crore|
|Clean Science & Technology||Rs. 1400 crore|
|GR Infraprojects||Rs. 1000 crore|
|Chemplast||Rs. 3500 crore|